Dengue antibodies for lateral-flow applications
Dengue virus is endemic in tropical countries worldwide. Mosquito-borne, the infection manifests as dengue fever, but can progress to more serious conditions including haemorrhagic fever. There are four serotypes of the virus and all are capable of causing disease. A non-structural glycoprotein (NS1) is produced during acute infection and can be found at high levels in patient serum.
ViroStat has now released several new monoclonal antibodies to the NS1 glycoprotein of the virus that recognise the NS1 protein of all four dengue serotypes. These antibodies have recently been validated for rapid lateral-flow immunoassay detection methods.
Other News
Featured Supplier
Haier Biomedical was founded in 1998 to focus on design, manufacturing and sales of reliable and durable products for clinicians and life scientists around the world. Using the concept of the Internet of Things (IoT), Haier Biomedical has become a leading provider of comprehensive solutions for many biotechnological challenges.
Haier...
Upcoming Events
Every Minute Counts: a SHOT, BBTS and NBTC joint webinar
Online
3 December 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
